Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-28T11:28:38.502Z Has data issue: false hasContentIssue false

Neuroleptic malignant syndrome and carbamazepine?

Published online by Cambridge University Press:  02 January 2018

Therese van Amelsvoort*
Affiliation:
Centre Hospitalier de Luxembourg 4, rue Barbie L-1210, Luxembourg
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

Macdonald, R. L. (1989) Carbamazepine: mechanisms of action. In Antiepileptic Drugs (3rd edn) (eds Levy, R., Mattson, R., Meldrum, B., et al), pp. 447455. New York: Raven Press.Google Scholar
O'Griofa, F. M. & Voris, J. C. (1991) Neuroleptic malignant syndrome associated with carbamazepine. Southern Medical Journal, 84, 13781380.10.1097/00007611-199111000-00023Google Scholar
Schmutz, M. (1992) Antiepileptics and the hippocampus. In The Temporal Lobes and the Limbic System (eds Trimble, M. R. & Bolwig, T. G., pp. 9199). Wrightson Biomedical Publishing.Google Scholar
Weller, M. & Kornhuber, J. (1992) Pathophysiologie und Therapie des malignen neuroleptischen Syndroms. Nervenarzt, 63, 645655.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.